Wave Life Sciences Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
WVE Nasdaq 8731 https://www.wavelifesciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Wave Life Sciences Ltd

Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia - May 23rd, 2023 11:30 am
Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting - May 16th, 2023 12:30 pm
The Consensus EPS Estimates For Wave Life Sciences Ltd. (NASDAQ:WVE) Just Fell Dramatically - May 8th, 2023 10:03 am
Wave Life Sciences First Quarter 2023 Earnings: Misses Expectations - May 5th, 2023 10:19 am
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates - May 3rd, 2023 12:55 pm
Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update - May 3rd, 2023 11:30 am
Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023 - Apr 26th, 2023 12:30 pm
Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry - Apr 20th, 2023 12:30 pm
Can Wave Life Sciences (NASDAQ:WVE) Afford To Invest In Growth? - Mar 29th, 2023 12:54 pm
Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days - Mar 29th, 2023 12:00 pm
Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2022 Earnings Call Transcript - Mar 24th, 2023 11:36 am
Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue Estimates - Mar 22nd, 2023 12:45 pm
Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update - Mar 22nd, 2023 11:30 am
Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 - Mar 2nd, 2023 1:30 pm
Wave Life Sciences (WVE) Upgraded to Buy: Here's What You Should Know - Feb 14th, 2023 5:00 pm
After Plunging -23.26% in 4 Weeks, Here's Why the Trend Might Reverse for Wave Life Sciences (WVE) - Feb 14th, 2023 2:35 pm
Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference - Feb 9th, 2023 9:05 pm
Wave Life Sciences (NASDAQ:WVE) shareholders have earned a 115% return over the last year - Jan 25th, 2023 11:06 am
Morphic Holding, Inc. (MORF) Surges 18.7%: Is This an Indication of Further Gains? - Jan 13th, 2023 12:26 pm
The Zacks Analyst Blog Highlights AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life Sciences - Jan 3rd, 2023 10:40 am